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Mitomycin C (MMC), a DNA-damaging agent, is a potent inducer of the bacterial SOS response; surprising-
ly, it has not been used to select resistant mutants from wild-type Escherichia coli. MMC resistance is caused
by the presence of any of four distinct E. coli genes (mdfA, gyrl, rob, and sdiA) on high-copy-number vectors.
mdfA encodes a membrane efflux pump whose overexpression results in broad-spectrum chemical resistance. The
gyrI (also called sbmC) gene product inhibits DNA gyrase activity in vitro, while the rob protein appears to
function in transcriptional activation of efflux pumps. SdiA is a transcriptional activator of ftsQAZ genes involved
in cell division.
Mitomycin C (MMC), an antitumor agent isolated from
Streptomyces cultures, is used in chemotherapy (30). It inter-
acts with DNA by intercalation and adduct formation (37).
These actions trigger the SOS response, the concerted in-
duction of several DNA repair, and recombination activities
controlled by the lexA-specified repressor in Escherichia coli
(42). This interaction has been studied by in vitro and in vivo
methods. The breadth of the SOS regulatory circuit has been
approximated by screening a collection of Escherichia coli
promoter-lacZYA gene fusions for those which displayed in-
creased b-galactosidase activity in the presence of low levels of
MMC (19). Similarly, two-dimensional electrophoretic separa-
tion of E. coli polypeptides induced by a DNA cleaving treat-
ment has been catalogued (38). The expression of at least 29
genes is induced by DNA damage; 18 of these are regulated by
the SOS response, while 11 are lexA independent (42).
Global regulatory circuits do not act in isolation (29). Ra-
ther, a stress treatment may induce many regulons, as has been
observed by both two-dimensional protein separation method-
ology in studies of Salmonella enterica serovar Typhimurium
(13) and gene fusion-based analyses of E. coli (7) after hydro-
gen peroxide treatment. The concerted action of all such in-
duced regulons describes the responses to the stress caused by
an individual chemical treatment. Such interactions may also
be suggested by the analysis of pleiotropic mutants (20) resis-
tant to DNA-damaging agents.
Despite the clinical, molecular biological, and historical im-
portance of MMC-DNA interactions, the selection of MMC-
resistant mutants has been limited to a single pseudoreversion
study (24, 26). Further genetic studies might enhance our un-
derstanding of the cellular interactions with MMC. Demand-
ing overexpression of a gene product is a classic means of
overcoming chemical toxicity (20). Such selections were used
to define the regulatory circuit controlling his operon expres-
sion in Salmonella serovar Typhimurium (32). This selection
system was later exploited to select gene amplification events
in bacteria (4). Similar selections with PALA, N-(phosphon-
acetyl)-L-aspartate, and methotrexate led to amplification of
specific genes encoding enzymes targeted by the inhibitors in
mammalian cells (34, 41). With the construction of yeast ge-
nomic DNA libraries in high-copy-number plasmids, the selec-
tion of inhibitor-resistant lines in yeast accelerated. Targets of
inhibitor action were verified by using these methods (31),
while the ability to define both target-specifying and unex-
pected resistance genes was uncovered (17). More recently,
these methodologies were extended to a tumoricidal agent
with an ill-defined mode of action using an E. coli-based mul-
ticopy plasmid library and a selection scheme (12). Such tech-
niques have also been used to define the action of amino acid
biosynthetic inhibitors (16; Z. Xue, D. R. Smulski, D. Delduco,
S.-Y. Choi, M. H. Jia, and R. A. LaRossa, unpublished results;
D.R.Smulski,L.X.Huang,T.K.VanDyk,andR.A.LaRossa,un-
published results).
In this study, the response to an MMC challenge was illu-
minated by the isolation of inhibitor-resistant mutants due to
the presence of E. coli genomic fragments in multicopy plas-
mids. The sequencing of insert-vector junctions defines genes
that confer inhibitor resistance when present in high copy. The
application of such technology to MMC action is described
here.
MATERIALS AND METHODS
Strains and media. The E. coli strains used in this study are all K-12 derivatives
(Table 1). The strains were grown in Luria-Bertani (LB) medium. Ampicillin (at
100 or 150 mg/ml) or kanamycin (at 25 mg/ml) was added to the medium when
necessary. The standard growth temperature was 37°C. Liquid cultures were
aerated by rotary shaking at 250 rpm.
Strain construction. DPD2272 was constructed by P1vir phage-mediated trans-
duction with the donor strain, WX2, and the recipient strain, MG1655. Recom-
binants were selected using kanamycin (23). An electrotransformation method
(33) was used to introduce plasmids into bacterial strains.
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MIC of MMC. LB agar plates containing different MMC concentrations (10,
8, 5, 3, 1, 0.5, 0.1, 0.05, 0.01, and 0 mg/ml) were prepared. Strain RFM443 was
streaked onto each plate, followed by incubation overnight at 37°C. The growth
of RFM443 was checked by scoring for colony formation. The lowest concen-
tration of MMC that inhibited colony formation of RFM443 was defined as the
MIC of MMC. Strain RFM443 grew on all the plates with an MMC concentra-
tion of #1 mg/ml; growth was prevented by a concentration of $3 mg/ml. The
MIC of MMC on plates for RFM443 was thus defined to be 3 mg/ml.
Identification of MMC-resistant clones. Libraries were previously prepared
from E. coli strain W3110 genomic DNA partially digested with Sau3AI to
;4-kbp fragments (16). For each round of multicopy titration, 0.2 ng of the
pBR322-based or 0.3 ng of the pUC18-based library was electrotransformed into
RFM443. The colonies underwent single colony purification on the same me-
dium. Plasmids were isolated from 1.5-ml overnight cultures of the single colo-
nies in LB medium supplemented with ampicillin (150 mg/ml) using the Qiagen
96-well Turbo Plasmid Prep kit (Qiagen, Inc., Valencia, Calif.). DNA sequence
data from both ends of each insert were obtained. The M13/pUC sequencing
primer (240) and the M13/pUC reverse sequencing primer (248) were used in
sequencing the pUC18-based inserts (33). The primers used in sequencing the
pBR322-based insertions were 59-GCC ACT ATC GAC TAC GCG-39 and
59-CGA TAT AGG CGC CAG CAA C-39. BLASTn (3) searches identified the
chromosomal segments harbored on each plasmid.
Subcloning of gyrI, sdiA, and rob. Primers were designed for PCR amplification
of gyrI, sdiA, and rob, each with the flanking intergenic regions containing the
corresponding promoter (Table 2). PCR amplification was carried out using the
PCR AmpliTaq kit (Roche, Palo Alto, Calif.). The EcoRI-BamHI double-di-
gested PCR product of the gyrI region was subcloned into the EcoRI-BamHI site
of pUC18, and the resultant plasmid was designated pDEW133. The PCR
products of the sdiA region and the rob region were each inserted into the
polylinker site of pCR2.1-TOPO vector using the TOPO TA Cloning Kit (In-
vitrogen Co., Carlsbad, Calif.), and both inserts were subsequently placed into
the EcoRI site of pUC19. The resultant plasmids were named pDEW140 and
pDEW141, respectively. Their structures were confirmed by sequencing the
insert junctions using the M13/pUC sequencing primer (240) and the M13/pUC
reverse sequencing primer (248). pDEW133, pDEW140, and pDEW141 were
electrotransformed into strains RFM443, DM800, and DM803 for further char-
acterization.
Zone of inhibition assays. These were performed using the method modified
(21) from that of Stephens et al. (36). Briefly, the test strains were grown
overnight in LB medium supplemented with 150 mg of ampicillin per ml. Then,
0.1-ml portions of each culture and 2.5 ml of melted LB soft agar with 150 mg of
of ampicillin per ml were mixed and poured over a 30-ml LB agar plate appended
with 150 mg of ampicillin per ml. After the top layer was solidified, a sterile filter
disc (7 mm in diameter) containing the desired amount of a chemical was placed
at the center of the plate. For MMC, 15 or 30 mg was used; for nalidixic acid, 75
mg was used. The diameters of the inhibition zones were measured after over-
night incubation at 37°C.
Microscopic examination of cultures. Both overnight and early-exponential-
phase aliquots of a control strain, DPD2668, and one having an sdiA multicopy
plasmid, DPD2669, were examined by confocal laser scanning microscopy. Por-
tions (1 ml) of cultures, grown at 37°C in LB medium, were stained with 1 ml of
SYTO13, a cell-permeant green fluorescent nucleic acid stain (5 mM solution in
dimethyl sulfoxide, Molecular Probes, Eugene, Oreg.). Samples (ca. 1 ml) were
spotted onto microscope slides and dried for 20 min by placement on a surface
heated to 60°C. They were rehydrated in a drop of a glycerol-based mounting
medium, Citifluor (Ted Pella, Inc., Redding, Calif.), designed to reduce photo-
bleaching, and a coverslip was placed over the sample prior to examination by
confocal laser scanning microscopy. Images were archived on a personal com-
puter.
RESULTS
sdiA, gyrI, rob, and mdfA in multicopy conferred resistance
to MMC upon E. coli. MMC-resistant clones were selected on
LB agar plates with 6 mg of MMC per ml (twice the MIC
determined in this study) and 150 mg of ampicillin per ml.
Resistant colonies appeared after 1 day of incubation at 37°C.
E. coli genomic DNA libraries in pUC18 and pBR322 were
separately transformed into strain W3110. Thirty MMC-resis-
tant isolates were found among approximately 109 ampicillin-
resistant colonies obtained from the pUC18 library. The plat-
ing of approximately 108 ampicillin-resistant colonies obtained
from the pBR322 library yielded 16 MMC-resistant clones.
Plasmids were isolated from each of these 46 lines and used to
retransform strain RFM443 selecting for ampicillin resistance.
In each backcross, MMC resistance was coinherited with am-
picillin resistance, indicating that the MMC resistance deter-
minants were plasmid-borne. The ends of these 46 inserts
conferring MMC resistance were sequenced to identify the
regions of the E. coli chromosome harbored within each mul-
ticopy plasmid. Inserts were derived from four distinct chro-
mosomal loci.
Four pUC18-derived plasmids and five pBR322-derived
plasmids contained a region of the genome that mapped to min
19 (Fig. 1A). The only gene present in all nine plasmids was
mdfA, suggesting that mdfA in multiple copies conferred MMC
resistance. Eighteen other pUC18-derived plasmids clustered
at a second locus, the gyrI (also known as sbmC) region of the
chromosome at min 44 (Fig. 1B). gyrI was the single gene in
common among the 18 inserts. Another cluster of 7 pUC18-
derived plasmids and 11 pBR322-derived plasmids shared a
single common gene, sdiA from min 43 (Fig. 1C). The final
pUC18-derived plasmid conferring MMC resistance contained
three intact E. coli genes, i.e., rob, creA, and creB (map not
shown), in the vicinity of min 100.
To confirm these assignments of resistance determinants,
the gyrI, sdiA, and rob genes with just their flanking intergenic
regions were individually inserted into either pUC18 or pUC19
TABLE 2. Primers used in genetic constructions
Primer Sequence (59-39)
gyrI Bam-left ..........CGGGATCCCGCCGCGCACCAGACTAACAT
gyrI Eco-right .........GGAATTCCGTCGGAACGGAACGCATCTGGTA
sdiAf ........................TGGCACGCAGGACAGAA
sdiAd .......................TAACAAATCAGCATAACTCAT
rob1 ..........................ACGACGGATCGGAATCAGCA
rob2 ..........................TAGTTCGTCACGGTAA
TABLE 1. Strains and plasmids used in this work
Strain or
plasmid Genotype
Source or
reference
E. coli
MG1655 F2 l2 rph-1 5
W3110 F2 l2 rph-1 IN(rrnD-rrnE) 5
RFM443 rpsL200 galK2 lacD74 22
WX2 Dlac-pro met pro zzz::Tn10
sdiA::Kan thy supD (rK
2 mK
2)
43
DM800 F2 metA28 lacY1 or lacZ4 thi-1
xyl-5 or xyl-7 galK2 tsx-6
25
DM803 Same as DM800 but lexA1a 25
DPD2272 F2 l2 rph-1 sdiA::Kan This studyb
DPD2668 RFM443(pUC19) This study
DPD2669 RFM443(pDEW140) This study
Plasmids
pBR322 Cloning vector 33
pUC18 Cloning vector 33
pUC19 Cloning vector 33
pDEW133 pUC18 plus gyrI This study
pDEW140 pUC19 plus sdiA (EcoRI) This study
pDEW141 pUC19 plus rob (EcoRI) This study
a lexA1 [also lexA(Ind)] is a noninducible allele of lexA.
bP1(WX2) 3 MG1655 3 Kanr.
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(see Materials and Methods). The resultant plasmids, when
introduced by transformation into strain RFM443, were tested
for their abilities to alter the strains’ responses to MMC and
nalidixic acid, an inhibitor of DNA gyrase that causes strand
scissions through interference with the gyrase ligation reaction
(42). The results (Table 3) demonstrated that each of these
three genes in multicopy conferred resistance to both MMC
and nalidixic acid, since strains bearing these genes in high
copy displayed smaller zones of inhibition than strains contain-
ing control plasmids.
An sdiA null mutant did not show hypersensitivity to MMC.
Inhibition zone assays were performed on the isogenic sdiA1
and sdiA strains MG1655 and DPD2272. Obvious differences
in the zones of inhibition caused by exposure to MMC or
nalidixic acid were not observed. Both strains showed 19-mm-
diameter zones of inhibition with 15 mg of MMC or 75 mg of
nalidixic acid.
Modulation of multicopy resistance to DNA-damaging
agents by lexA (Ind). Strain DM800 (lexA1) and strain DM803
[lexA (Ind)], each individually transformed with a set of plas-
mids (pUC18, pUC19, pDEW133 [gyrI], pDEW140 [sdiA], and
pDEW141 [rob]), were tested for MMC and nalidixic acid
sensitivities (Tables 4 and 5). The lexA (Ind) product is resis-
tant to proteolysis by activated RecA and thus prevents in-
duction of the SOS response (42). As expected, the lexA (Ind)
mutants displayed larger zones of inhibition than those of the
isogenic lexA1 strain. A multicopy gyrI plasmid (pDEW133) in
the lexA(Ind) background did not confer significant resistance
to either MMC or nalidixic acid. Thus, the SOS response was
needed for the gyrI-associated phenotype. In contrast, the pres-
ence of sdiA in high copy (pDEW140) conferred resistance in
both the lexA1 and lexA(Ind) backgrounds. Thus, the pheno-
type conferred by sdiA amplification did not rely upon the SOS
response. rob in high copy (pDEW141) did not confer signifi-
cant resistance in the DM800/DM803 background used for
testing lexA(Ind) dependence (data not shown).
Microscopic examination of cultures harboring an sdiA
plasmid. In the early exponential phase the DPD2668 (con-
trol) culture displayed a typical rod-shaped morphology, and in
stationary phase the culture was composed of rods that might
be slightly shorter than cells in the exponential phase of growth.
In contrast, the stationary-phase culture of DPD2669 (harbor-
ing sdiA in high copy) was dominated by rounded cells that
transformed into rods upon reaching logarithmic growth after
subculturing. These rods were significantly shorter than those
TABLE 4. gyrI-mediated multicopy resistance is lexA dependent
Strain
Inhibition zone diam (mm) with:
MMC (30 mg) Nalidixic acid (75 mg)
DM800/pUC18 17 19
DM803/pUC18 22 22
DM800/pDEW133 (gyrI) 12 19
DM803/pDEW133 (gyrI) 22 22
FIG. 1. Physical maps of E. coli genomic inserts conferring mito-
mycin resistance. “L” and “H” are plasmid names (e.g., L13 and H7),
with “L” referring to pBR322-based plasmids and “H” referring to
pUC18-based plasmids. (A) Region from min 9 in E. coli, where
nine MMC-resistant clones were clustered (GenBank accession no.
AE000186). (B) Region from min 44, where 18 MMC-resistant clones
were clustered (GenBank accession no. AE000292). (C) Region from
min 43, where 18 MMC-resistant clones were clustered (GenBank
accession no. AE000284).
TABLE 3. Zone of inhibition assaysa
Plasmid
Inhibition zone diam (mm) with:
MMC (15 mg) Nalidixic acid (75 mg)
pUC19 22 23
pDEW140 (sdiA) 16 16
pDEW141 (rob) 19 18
pUC18 19 19
pDEW133 (gyrI) 12 ,7
a RFM443, harboring various plasmids, was challenged with either 15 mg of
MMC or 75 mg of nalidixic acid. The diameter of each resultant inhibition zone
is presented.
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observed in the early-exponential-phase control culture. Rep-
resentative fields of equal magnification are shown in Fig. 2.
In contrast, exponential- and stationary-phase E. coli cul-
tures harboring either mdfA or rob on a multicopy plasmid
displayed a morphology indistinguishable from that of the con-
trol cultures of DPD2668. The gyrI-containing plasmid, how-
ever, was associated with an intermediate phenotype having a
rounded morphology in the stationary phase but a normal
shape in the exponential phase.
DISCUSSION
Random E. coli genomic DNA fragments on a medium-
copy-number vector, pBR322, and a high-copy-number vector,
pUC18, were screened in an E. coli K-12 strain for variants
resistant to MMC, a DNA-damaging agent. The clones ob-
tained were clustered at four chromosomal regions. Only one
gene in each region was responsible for the MMC resistance
phenotype; these genes are mdfA, sdiA, rob, and gyrI.
Since mdfA is a multidrug resistance locus (15), the demon-
stration that resistance was conferred by minimal plasmids
expressing only one E. coli gene was restricted to the analysis
of rob, sdiA, and gyrI. One chromosomal region, defined by a
single plasmid, contained rob and creBC. Since rob is involved
in drug resistance (45), while creBC functions in carbon me-
tabolism (10), rob was subcloned and shown to confer resis-
tance to MMC when present at a high copy number.
The finding that these four genes confer resistance, though
unanticipated, can be incorporated into a plausible model. The
gyrI product inhibits DNA gyrase activity in vitro (28), while
the sdiA product activates the transcription of ftsQAZ, genes
involved in septum formation at an early stage of cell division
(43). SdiA also activates the expression of several other genes
(1, 44), including uvrY and uvrC, which are involved in the
protection of the cells from UV irradiation, and the acrA, acrB,
acrD, acrE, and acrF genes, whose products are responsible for
acridine efflux. The rob product also appears to function in
transcriptional activation of efflux pump genes, including the
acrAB operon (9, 27, 45). AcrAB connects to form an export
channel with the tolC-encoded outer membrane porin (2).
Since tolC mutants are hypersensitive to MMC (14), we pro-
pose that MMC is exported from cells by the action of the
efflux pumps, while DNA gyrase activity facilitates the inter-
calation of MMC into the chromosome. Thus, amplification of
gyrI and mdfA may prevent MMC from interacting with DNA,
its macromolecular target. Amplification of gyrI has previously
been shown to protect cells from the action of microcin B17, a
DNA-cleaving agent (6). This compound causes double-strand-
ed DNA breaks in vivo and in vitro only in concert with DNA
gyrase (39). Perhaps, rob overexpression also acts to enhance
efflux, while elevated levels of the sdiA product might over-
come cell division arrest imposed by DNA damage. Thus, ex-
haustive selection of multicopy resistance, in conjunction with
previous knowledge of MMC action, has allowed us to define
the integrated response to this chemical insult.
Both MMC and nalidixic acid are known to induce the SOS
response in E. coli (38, 42). While the lexA1 strain, DM800,
showed sensitivity to MMC and nalidixic acid, strain DM803
[lexA(Ind)], which is incapable of mounting the SOS response
due to a noncleavable form of the LexA repressor, showed an
increased sensitivity to both chemicals. In the lexA(Ind) back-
ground, the strains harboring pUC18 or the gyrI-containing
pDEW133 both displayed inhibition zones of the same size
when challenged with MMC. This indicates that gyrI in multi-
copy did not confer resistance in DM803. Thus, gyrI multicopy-
mediated resistance to MMC was dependent upon lexA func-
tion; this gyrI function was thus defined to be a part of the SOS
response; a result congruent with other studies of this gene (6).
In contrast, multicopy sdiA conferred resistance to MMC or
nalidixic acid in both lexA1 and lexA(Ind) backgrounds, sug-
gesting that this phenotype was at least not directly related to
the lexA and recA circuitry which defines the SOS response. It
was not clear to us why gyrI amplification in strain DM800 did
not confer resistance to nalidixic acid as it did to MMC. This,
at least, reflects differences in the action of the two chemicals.
That rob amplification did not confer resistance in a DM800 or
DM803 strain background reinforces that MMC resistance is a
complex trait influenced by several genetic factors.
While sdiA conferred resistance in multicopy, a null muta-
tion in sdiA did not result in hypersensitivity to MMC. It has
been observed that the strain with sdiA in high copy, DPD2669,
forms rounder and shorter cells than control cells in both the
FIG. 2. Micrographs of E. coli cells. Each frame is enlarged to the
same extent. The top two panels capture images of cells with a haploid
sdiA (DPD2668) content, while the bottom two panels are of an iso-
genic strain containing multiple copies of sdiA (DPD2669). The first
and third frames from the top are pictures of stationary (stat.)-phase
cultures, while the second and fourth panels from the top are images
of exponential (exp.)-phase cultures. Color differences in the images of
the two strains are a result of computer processing.
TABLE 5. Modulation of sdiA multicopy resistance
Strain
Inhibition zone diam (mm) with:
MMC (15 mg) Nalidixic acid (75 mg)
DM800/pUC19 20 20
DM803/pUC19 27 25
DM800/pDEW140 (sdiA) ,7 8
DM803/pDEW140 (sdiA) 16 13
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exponential and the stationary growth phases, and the same
strain forms slightly shorter cells in the stationary phase than
those in the exponential phase. These observations agree with
the knowledge that sdiA overexpression speeds up cell division
(43), and the expression of sdiA is decreased 50 to 80% in mid-
to late-exponential growth phase with the appearance of an
extracellular factor in the growth medium that specifically
downregulates sdiA expression (18). It is also known that sdiA
null mutants did not have obviously different phenotypes in cell
division or growth (18). This may be because sdiA encodes a
transcriptional activator only partially responsible for expres-
sion of the cell division genes ftsQAZ. Expression of ftsQAZ is
controlled by at least two regulators, RpoS and SdiA (35).
Eliminating SdiA function does not prevent ftsQAZ expres-
sion, while amplification of sdiA results in overproduction of
ftsQAZ transcripts (44). In contrast, amplification of gyrI en-
coding a protein that inhibits DNA supercoiling, increased
resistance to MMC (this work), while a null mutation in gyrI
resulted in a strain that is twofold more sensitive to MMC and
another DNA-damaging agent, microcin B17 (6).
Biosensors that can detect genotoxic agents have been de-
veloped (8, 40), providing one means of categorizing different
DNA-damaging agents. The genetic titration of inhibitor ac-
tion, coupled with the completed E. coli genomic sequence (11)
and the availability of high-throughput, automated sequencing
facilities, has proven to be a very powerful technique for the
characterization of one DNA-damaging agent, MMC. The
broad application of this methodology to several DNA-dam-
aging agents may be quite informative.
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